Louisiana State Employees Retirement System Makes New Investment in Perrigo Company plc (NYSE:PRGO)

Louisiana State Employees Retirement System acquired a new position in shares of Perrigo Company plc (NYSE:PRGOFree Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 38,100 shares of the company’s stock, valued at approximately $1,226,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Ronald Blue Trust Inc. increased its position in shares of Perrigo by 132.3% during the 3rd quarter. Ronald Blue Trust Inc. now owns 1,157 shares of the company’s stock worth $39,000 after purchasing an additional 659 shares during the last quarter. Blue Trust Inc. increased its position in shares of Perrigo by 34.5% during the 4th quarter. Blue Trust Inc. now owns 1,556 shares of the company’s stock worth $50,000 after purchasing an additional 399 shares during the last quarter. Fifth Third Bancorp increased its position in shares of Perrigo by 39.5% during the 3rd quarter. Fifth Third Bancorp now owns 1,714 shares of the company’s stock worth $55,000 after purchasing an additional 485 shares during the last quarter. TFC Financial Management Inc. acquired a new stake in shares of Perrigo during the 3rd quarter worth about $78,000. Finally, Mitsubishi UFJ Trust & Banking Corp acquired a new stake in shares of Perrigo during the 3rd quarter worth about $97,000. 95.91% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Perrigo

In other Perrigo news, CEO Patrick Lockwood-Taylor purchased 9,500 shares of the stock in a transaction that occurred on Thursday, February 29th. The stock was purchased at an average cost of $26.54 per share, with a total value of $252,130.00. Following the completion of the acquisition, the chief executive officer now directly owns 20,500 shares of the company’s stock, valued at approximately $544,070. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Alison Ives purchased 2,490 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was acquired at an average price of $27.26 per share, for a total transaction of $67,877.40. Following the completion of the purchase, the executive vice president now directly owns 16,122 shares of the company’s stock, valued at $439,485.72. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Patrick Lockwood-Taylor purchased 9,500 shares of the business’s stock in a transaction dated Thursday, February 29th. The shares were bought at an average price of $26.54 per share, with a total value of $252,130.00. Following the purchase, the chief executive officer now directly owns 20,500 shares of the company’s stock, valued at $544,070. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 17,990 shares of company stock valued at $475,227. Corporate insiders own 0.40% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Canaccord Genuity Group reissued a “buy” rating and set a $42.00 price objective on shares of Perrigo in a research report on Friday, April 12th. StockNews.com upgraded Perrigo from a “hold” rating to a “buy” rating in a report on Wednesday, April 3rd. Piper Sandler raised their target price on Perrigo from $35.00 to $39.00 and gave the company an “overweight” rating in a report on Monday, April 8th. Finally, JPMorgan Chase & Co. lowered their target price on Perrigo from $48.00 to $41.00 and set an “overweight” rating for the company in a report on Wednesday, February 28th.

Check Out Our Latest Research Report on PRGO

Perrigo Stock Performance

Shares of PRGO opened at $30.06 on Tuesday. The stock has a 50-day simple moving average of $30.58 and a 200-day simple moving average of $30.78. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.07 and a current ratio of 1.79. The stock has a market capitalization of $4.07 billion, a PE ratio of -300.60 and a beta of 0.64. Perrigo Company plc has a 1 year low of $25.77 and a 1 year high of $40.28.

Perrigo (NYSE:PRGOGet Free Report) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.03. The business had revenue of $1.16 billion during the quarter, compared to analysts’ expectations of $1.17 billion. Perrigo had a positive return on equity of 7.34% and a negative net margin of 0.27%. The business’s quarterly revenue was up .1% compared to the same quarter last year. During the same quarter last year, the business posted $0.75 EPS. On average, analysts predict that Perrigo Company plc will post 2.55 earnings per share for the current fiscal year.

Perrigo Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were paid a $0.276 dividend. This represents a $1.10 annualized dividend and a dividend yield of 3.67%. The ex-dividend date was Thursday, March 7th. This is a boost from Perrigo’s previous quarterly dividend of $0.27. Perrigo’s dividend payout ratio (DPR) is presently -1,100.00%.

Perrigo Profile

(Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Featured Articles

Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGOFree Report).

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.